📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Kadmon

1.1 - Company Overview

Kadmon Logo

Kadmon

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical products and services for the treatment and management of hepatitis C, including Ribasphere RibaPak (ribavirin, USP) tablets that reduce pill burden and deliver treatment biologically equivalent to other ribavirin medications, and INFERGEN (interferon).

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Kadmon

Tvardi Therapeutics Logo

Tvardi Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology development as a private company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tvardi Therapeutics company profile →
Deka Biosciences Logo

Deka Biosciences

HQ: United States Website
  • Description: Provider of cytokine therapy platforms, including Diakine™ combining cytokines in a single treatment for cancer and inflammatory diseases; an oncology platform with disease-targeting scaffolds that link cytokines to stimulate the immune system; an anti-inflammatory platform targeting specific tissue markers; precision medicine using genetic tests to personalize Diakines™; and manufacturing via a unique scaffold for higher yields and lower costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Deka Biosciences company profile →
Amira Pharmaceuticals Logo

Amira Pharmaceuticals

HQ: United States Website
  • Description: Provider of small-molecule pharmaceutical research focused on the discovery and early development of new drugs to treat inflammatory disease, leveraging unparalleled insights into bioactive lipid pathways and complex signaling processes controlling conditions including asthma.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amira Pharmaceuticals company profile →
Amagma Therapeutics Logo

Amagma Therapeutics

HQ: United States Website
  • Description: Provider of discovery and development of antibody therapeutics targeting inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amagma Therapeutics company profile →
OMass Therapeutics Logo

OMass Therapeutics

HQ: United Kingdom Website
  • Description: Provider of drug discovery leveraging novel mass spectrometry, offering the OdyssION platform that uses native mass spectrometry and custom chemistry to study target interactions in native ecosystems, and a small molecule pipeline targeting solute carriers, inflammasome complexes, and GPCRs for orphan and immunological diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OMass Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Kadmon

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Kadmon

2.2 - Growth funds investing in similar companies to Kadmon

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Kadmon

4.2 - Public trading comparable groups for Kadmon

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Kadmon

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Kadmon

What does Kadmon do?

Kadmon is a provider of biopharmaceutical products and services for the treatment and management of hepatitis C, including Ribasphere RibaPak (ribavirin, USP) tablets that reduce pill burden and deliver treatment biologically equivalent to other ribavirin medications, and INFERGEN (interferon).

Who are Kadmon's competitors?

Kadmon's competitors and similar companies include Tvardi Therapeutics, Deka Biosciences, Amira Pharmaceuticals, Amagma Therapeutics, and OMass Therapeutics.

Where is Kadmon headquartered?

Kadmon is headquartered in United States.

How many employees does Kadmon have?

Kadmon has 1,000 employees 🔒.

When was Kadmon founded?

Kadmon was founded in 2010 🔒.

What sector and industry vertical is Kadmon in?

Kadmon is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Kadmon

Who are the top strategic acquirers in Kadmon's sector and industry

Top strategic M&A buyers and acquirers in Kadmon's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Kadmon?

Top strategic M&A buyers groups and sectors for Kadmon include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Kadmon's sector and industry vertical

Which are the top PE firms investing in Kadmon's sector and industry vertical?

Top PE firms investing in Kadmon's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Kadmon's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Kadmon's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Kadmon's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Kadmon include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Kadmon's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Kadmon?

The key public trading comparables and valuation benchmarks for Kadmon include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Kadmon for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Kadmon with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Kadmon's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Kadmon with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Kadmon's' sector and industry vertical?

Access recent funding rounds and capital raises in Kadmon's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Kadmon